Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Meya

Showing results (91-100 of 260) with videos related to

Pageof 26
Sort By:
Open Forum Infectious Diseases|June 27, 2018
Cerebral Oximetry for Detecting High-mortality Risk Patients with Cryptococcal MeningitisJohn W Diehl, Katherine H Hullsiek, Michael Okirwoth, et al.
Medical Mycology|February 9, 2018
Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluidRichard Kwizera, Andrew Akampurira, Tadeo K Kandole, et al.
Frontiers in Cellular and Infection Microbiology|July 12, 2021
ATI-2307 Exhibits Equivalent Antifungal Activity in <i>Cryptococcus neoformans</i> Clinical Isolates With High and Low Fluconazole IC<sub>50</sub>Elliot S Gerlach, Sophie Altamirano, J Marina Yoder, et al.
Open Forum Infectious Diseases|August 18, 2019
Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction ModelSupavit Chesdachai, Radha Rajasingham, Melanie R Nicol, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Detection of Cryptococcus DNA by Metagenomic Next-generation Sequencing in Symptomatic Cryptococcal AntigenemiaPrashanth S Ramachandran, Fiona V Cresswell, David B Meya, et al.
Open Forum Infectious Diseases|March 4, 2015
Standardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settingsNathan C Bahr, Melissa A Rolfes, Abdu Musubire, et al.
BMC Infectious Diseases|July 15, 2025
Experience of research nurses with oral encochleated amphotericin B for treatment of cryptococcal meningitis in a resource-limited settingCynthia Ahimbisibwe, Richard Kwizera, Jane Frances Ndyetukira, et al.
Plos One|May 17, 2019
Burden of fungal asthma in Africa: A systematic review and meta-analysisRichard Kwizera, Joseph Musaazi, David B Meya, et al.
The Journal of Infectious Diseases|June 20, 2024
Postmortem Analysis of Dolutegravir, Tenofovir, Lamivudine, and Efavirenz Penetration in Multiple Central Nervous System CompartmentsFan Wang, Kara Rademeyer, Olivie C Namuju, et al.
Open Forum Infectious Diseases|July 29, 2017
Acute Kidney Injury and Urinary Biomarkers in Human Immunodeficiency Virus-Associated Cryptococcal MeningitisCharlotte Schutz, David R Boulware, Katherine Huppler-Hullsiek, et al.
Pageof 26

Showing results (91-100 of 260) with videos related to

Sort By:
Pageof 26
Open Forum Infectious Diseases|June 27, 2018
Cerebral Oximetry for Detecting High-mortality Risk Patients with Cryptococcal MeningitisJohn W Diehl, Katherine H Hullsiek, Michael Okirwoth, et al.
Medical Mycology|February 9, 2018
Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluidRichard Kwizera, Andrew Akampurira, Tadeo K Kandole, et al.
Frontiers in Cellular and Infection Microbiology|July 12, 2021
ATI-2307 Exhibits Equivalent Antifungal Activity in <i>Cryptococcus neoformans</i> Clinical Isolates With High and Low Fluconazole IC<sub>50</sub>Elliot S Gerlach, Sophie Altamirano, J Marina Yoder, et al.
Open Forum Infectious Diseases|August 18, 2019
Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction ModelSupavit Chesdachai, Radha Rajasingham, Melanie R Nicol, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Detection of Cryptococcus DNA by Metagenomic Next-generation Sequencing in Symptomatic Cryptococcal AntigenemiaPrashanth S Ramachandran, Fiona V Cresswell, David B Meya, et al.
Open Forum Infectious Diseases|March 4, 2015
Standardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settingsNathan C Bahr, Melissa A Rolfes, Abdu Musubire, et al.
BMC Infectious Diseases|July 15, 2025
Experience of research nurses with oral encochleated amphotericin B for treatment of cryptococcal meningitis in a resource-limited settingCynthia Ahimbisibwe, Richard Kwizera, Jane Frances Ndyetukira, et al.
Plos One|May 17, 2019
Burden of fungal asthma in Africa: A systematic review and meta-analysisRichard Kwizera, Joseph Musaazi, David B Meya, et al.
The Journal of Infectious Diseases|June 20, 2024
Postmortem Analysis of Dolutegravir, Tenofovir, Lamivudine, and Efavirenz Penetration in Multiple Central Nervous System CompartmentsFan Wang, Kara Rademeyer, Olivie C Namuju, et al.
Open Forum Infectious Diseases|July 29, 2017
Acute Kidney Injury and Urinary Biomarkers in Human Immunodeficiency Virus-Associated Cryptococcal MeningitisCharlotte Schutz, David R Boulware, Katherine Huppler-Hullsiek, et al.
Pageof 26